Compare
CHS Inc vs Andersons, Inc. vs Pyxus International, Inc.
| Latest fiscal year | CHS Inc CHSCP | Andersons, Inc. ANDE | Pyxus International, Inc. PYYX |
|---|---|---|---|
| Year ended | 2025-08-31 | 2025-12-31 | 2026-03-31 |
| Revenue | $35.46B | $11.01B | $2.41B |
| Revenue growth (YoY) | -9.7% | -2.2% | -2.8% |
| Gross margin | 3.2% | 6.5% | 14.4% |
| Operating margin | 0.3% | n/a | 6.7% |
| Net margin | 1.7% | 0.9% | 0.6% |
| Net income | $597.92M | $95.71M | $14.57M |
| EPS (Diluted) | n/a | n/a | $0.56 |
| Operating cash flow | $635.79M | $177.00M | -$208.45M |
| Free cash flow | -$92.79M | -$56.12M | -$230.50M |
| Cash & equivalents | $327.83M | $98.28M | $134.34M |
| Total assets | $18.86B | $3.71B | $1.69B |
| Total liabilities | n/a | $2.42B | $1.51B |
| Shareholders' equity | $11.08B | $1.29B | $181.11M |
| Return on year-end equity | 5.4% | 7.4% | 8.0% |
| Shares outstanding | n/a | n/a | 24.61M |
Revenue, most recent five fiscal years
| Fiscal year | CHS Inc | Andersons, Inc. | Pyxus International, Inc. |
|---|---|---|---|
| Latest | $35.46B Ended 2025-08-31 | $11.01B Ended 2025-12-31 | $2.41B Ended 2026-03-31 |
| 1 year earlier | $39.26B Ended 2024-08-31 | $11.26B Ended 2024-12-31 | $2.48B Ended 2025-03-31 |
| 2 years earlier | $45.59B Ended 2023-08-31 | $14.75B Ended 2023-12-31 | $2.03B Ended 2024-03-31 |
| 3 years earlier | $47.79B Ended 2022-08-31 | $17.33B Ended 2022-12-31 | $1.91B Ended 2023-03-31 |
| 4 years earlier | $38.45B Ended 2021-08-31 | $12.61B Ended 2021-12-31 | $1.64B Ended 2022-03-31 |